Cargando…
Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion
Stunning and cumulative ischemic dysfunction occur in the left ventricle with coronary balloon occlusion. Glucagon-like peptide (GLP)-1 protects the left ventricle against this dysfunction. This study used a conductance catheter method to evaluate whether the right ventricle (RV) developed similar d...
Autores principales: | Giblett, Joel P., Axell, Richard G., White, Paul A., Aetesam-Ur-Rahman, Muhammad, Clarke, Sophie J., Figg, Nicola, Bennett, Martin R., West, Nick E.J., Hoole, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488814/ https://www.ncbi.nlm.nih.gov/pubmed/31061924 http://dx.doi.org/10.1016/j.jacbts.2018.12.002 |
Ejemplares similares
-
Stunning and Right Ventricular Dysfunction Is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights From Right Ventricular Conductance Catheter Studies
por: Axell, Richard G., et al.
Publicado: (2017) -
Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia
por: Giblett, Joel P., et al.
Publicado: (2016) -
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies
por: Giblett, Joel P., et al.
Publicado: (2016) -
GLP‐1 Is a Coronary Artery Vasodilator in Humans
por: Clarke, Sophie J., et al.
Publicado: (2018) -
GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated
por: Aetesam-ur-Rahman, Muhammad, et al.
Publicado: (2021)